ASND Stock Ownership Activity

ASCENDIS PHARMA A/S - ADR 13F holders

1 value investing guru has made changes to the ASCENDIS PHARMA A/S - ADR (ASND) position according to the gurus' latest SEC quarterly report(s). The number of ASND shares has been increased by 1 super investor(s).

Which gurus or hedge funds are buying ASND now?

According to the latest SEC filing(s) ASCENDIS PHARMA A/S - ADR (ASND) has been bought by David M. Polen - Polen Capital Management (added shares +49.63%).

To see more about who is investing in ASCENDIS PHARMA A/S - ADR (ASND), please go to the ASND ownership page.

2026 Q1 (1 result)
David M. Polen
+49.63%
+601
+0.00%
0.00%
Reported price*: $228.73
2025 Q4 (1 result)
David M. Polen
-56.22%
-1,555
-0.00%
0.00%
Reported price*: $213.24
2025 Q3 (1 result)
David M. Polen
+1.73%
+47
+0.00%
0.00%
Reported price*: $198.81
2025 Q2 (1 result)
David M. Polen
buy
+2,719
+0.00%
0.00%
Reported price*: $172.60
2021 Q4 (1 result)
Stephen Mandel
-100.00%
-1,436,981
-0.94%
0.00%
Reported price*: $159.39
2021 Q1 (1 result)
Stephen Mandel
+60.64%
+542,448
+0.25%
0.67%
Reported price*: $128.88
2020 Q4 (1 result)
Stephen Mandel
buy
+894,533
+0.54%
0.54%
Reported price*: $166.78
7 of 7

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.